The study will test an artificial pancreas system’s ability to function outside of a hospital setting. Similar outpatient trials are currently being conducted in Europe.
The artificial pancreas is an external device under development that works by combining a continuous glucose monitor and an insulin pump with computer software that automatically provides the correct amount of insulin.
The development of an artificial pancreas is one of JDRF’s top priorities. JDRF is supporting the Artificial Pancreas Consortium, an international research group that “aims to speed and optimize the process of linking continuous glucose sensors and insulin pumps,” according to a description of the group.
Related Articles on FDA Clearances and Approvals:
Olympus Receives FDA Clearance for Thunderbeat Hand Instruments
JAMA Article Encourages FDA to Return Device Applications Lacking Trial Data on Women
Proposed Bill Would Tighten FDA Oversight of Medical Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.